Ob-R Activators
The assemblage of chemical entities enumerated above collectively defines a distinctive category termed "Ob-R Activators," each demonstrating varied mechanisms aimed at directly or indirectly enhancing the functional activity of the Ob-R receptor. Leptin and Ghrelin, representing endogenous ligands for Ob-R, enact a direct activation of the receptor by initiating a cascade of downstream signaling events, thereby elucidating the pivotal role of these ligands in the activation of Ob-R and associated pathways. AG-490 and SOCS3 Inhibitor operate through the modulation of JAK-STAT signaling, indirectly fortifying Ob-R activity by forestalling negative feedback mechanisms that would otherwise curtail the receptor's activation. This strategic intervention emphasizes the intricate interplay within the signaling pathways associated with Ob-R activation. CNTF and Melanocortin Receptor Agonists emerge as direct activators of Ob-R, instigating receptor phosphorylation and subsequent downstream signaling events. This direct modulation delineates a specific class of compounds with targeted impacts on Ob-R functionality, elucidating the diversity in regulatory mechanisms.
Furthermore, Liraglutide, Rosiglitazone, and Metformin contribute to indirect support for Ob-R functionality by orchestrating modulations in insulin sensitivity and energy-sensing pathways. This nuanced approach highlights the cross-talk between Ob-R and metabolic pathways, showcasing the multifaceted nature of cellular responses associated with these compounds. N-Acetyl Cysteine (NAC) and AICAR intricately influence cellular redox balance and energy homeostasis, respectively, indirectly bolstering Ob-R activity within the broader context of cellular processes. The integration of these compounds into the repertoire of Ob-R activators emphasizes the multifactorial nature of cellular responses orchestrated by Ob-R. Irisin stands out as a direct enhancer of Ob-R activity, fostering receptor activation and subsequent downstream signaling events. This direct interaction adds another layer to the intricate network of Ob-R modulators, providing specificity in the activation of this receptor.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ob (hBA-147) | sc-4912 | 1000 µg | $258.00 | 1 | ||
Leptin, the endogenous ligand for Ob-R, directly activates Ob-R by binding and initiating downstream signaling cascades. Binding of leptin to Ob-R leads to receptor dimerization, phosphorylation of associated kinases, and activation of JAK-STAT signaling pathways, ultimately enhancing Ob-R functional activity and triggering cellular responses involved in metabolism and energy homeostasis. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG-490, a JAK2 inhibitor, indirectly enhances Ob-R activity by targeting the JAK-STAT signaling pathway. Inhibition of JAK2 prevents the negative feedback loop on Ob-R, ensuring sustained receptor activation and amplification of downstream signaling events. AG-490, by modulating the JAK-STAT pathway, promotes enhanced Ob-R functionality associated with metabolic regulation. | ||||||
Liraglutide | 204656-20-2 | sc-507404 | 1 mg | $220.00 | ||
Liraglutide, a GLP-1 receptor agonist, indirectly enhances Ob-R activity by influencing insulin signaling pathways. Activation of GLP-1 receptors by Liraglutide leads to increased insulin sensitivity and downstream signaling events, indirectly supporting Ob-R functionality associated with metabolic regulation. The enhanced insulin signaling contributes to improved Ob-R responsiveness and activation in cellular processes involved in energy homeostasis. | ||||||
Ghrelin (human) | 258279-04-8 | sc-364689 sc-364689A | 0.5 mg 1 mg | $186.00 $298.00 | 3 | |
Ghrelin, an endogenous ligand for Ob-R, directly activates Ob-R by binding and initiating downstream signaling cascades. Binding of ghrelin to Ob-R leads to receptor dimerization, phosphorylation of associated kinases, and activation of JAK-STAT signaling pathways, ultimately enhancing Ob-R functional activity and triggering cellular responses involved in appetite regulation and energy homeostasis. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR indirectly enhances Ob-R activity by activating AMP-activated protein kinase (AMPK) and influencing energy-sensing pathways. AMPK activation by AICAR leads to improved cellular energy balance, indirectly supporting Ob-R functionality associated with metabolic regulation. The enhanced energy-sensing pathways contribute to increased Ob-R responsiveness and activation in cellular processes involved in energy homeostasis. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPAR-gamma agonist, indirectly enhances Ob-R activity by modulating insulin sensitivity and signaling pathways. Activation of PPAR-gamma by Rosiglitazone leads to improved insulin responsiveness, indirectly supporting Ob-R functionality associated with metabolic regulation. The enhanced insulin signaling contributes to increased Ob-R activation in cellular processes involved in energy homeostasis. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
NAC indirectly enhances Ob-R activity by modulating oxidative stress and cellular redox balance. NAC, as an antioxidant, reduces oxidative stress, indirectly supporting Ob-R functionality associated with metabolic regulation. The modulation of redox balance contributes to increased Ob-R responsiveness and activation in cellular processes involved in energy homeostasis. | ||||||